Metosuccinat Sandoz (Metoprolol Tartrate)

Metoprolol tartrate selectively blocks β1‑adrenergic receptors in the heart, decreasing sympathetic stimulation. This results in a slower heart rate, reduced contractile force, and lower cardiac output, which together lower blood pressure and myocardial oxygen demand. It also suppresses renin release from the kidneys, contributing to its antihypertensive effect.

The appropriate dose of Metosuccinat Sandoz is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any comorbidities. Dosing may be started low and titrated upward, but exact regimens should always follow the prescriber’s instructions and local prescribing guidelines.

Safety data for metoprolol tartrate in pregnancy are limited, and the drug is generally classified as use‑only if the potential benefit outweighs the risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers. Physicians should evaluate each case individually and discuss possible risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Metosuccinat Sandoz. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Metoprolol tartrate is a cardio‑selective β1‑blocker, offering a favorable profile for patients with respiratory disease compared with non‑selective agents like propranolol. Compared with atenolol, metoprolol has a shorter half‑life and may require more frequent dosing, but both provide similar reductions in heart rate and blood pressure. Choice often depends on patient tolerance, comorbidities, and physician preference.

Metosuccinat Sandoz tablets should be stored at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

The medication is taken orally, usually with a glass of water. It can be administered with or without food, but consistency with meals may help minimise gastrointestinal discomfort. Patients should swallow the tablet whole and avoid crushing or chewing unless specifically instructed by a healthcare professional.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, severe shortness of breath, chest pain, or signs of an allergic response.

Metosuccinat Sandoz is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, cardiogenic shock, and uncontrolled heart failure. Caution is also advised in individuals with severe asthma or chronic obstructive pulmonary disease.